These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8890393

  • 1. Mechanism of stone formation.
    Mandel N.
    Semin Nephrol; 1996 Sep; 16(5):364-74. PubMed ID: 8890393
    [Abstract] [Full Text] [Related]

  • 2. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A, Meschi T, Schianchi T, Allegri F, Novarini A, Borghi L.
    Acta Biomed; 2002 Sep; 73(1-2):11-26. PubMed ID: 12233273
    [Abstract] [Full Text] [Related]

  • 3. Crystallization inhibitors in the pathophysiology and treatment of nephrolithiasis.
    Marangella M, Bagnis C, Bruno M, Vitale C, Petrarulo M, Ramello A.
    Urol Int; 2004 Sep; 72 Suppl 1():6-10. PubMed ID: 15133325
    [Abstract] [Full Text] [Related]

  • 4. [*calcium-oxalate lithogenesis: crystallization in the presence of urine from healthy subjects].
    Beaufays JP, Bouche R, Boistelle R.
    Nephrologie; 1995 Sep; 16(4):325-31. PubMed ID: 7630471
    [Abstract] [Full Text] [Related]

  • 5. Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research.
    Kavanagh JP.
    Scanning Microsc; 1992 Sep; 6(3):685-704; discussion 704-5. PubMed ID: 1439665
    [Abstract] [Full Text] [Related]

  • 6. Urease. The primary cause of infection-induced urinary stones.
    Griffith DP, Musher DM, Itin C.
    Invest Urol; 1976 Mar; 13(5):346-50. PubMed ID: 815197
    [Abstract] [Full Text] [Related]

  • 7. Do "inhibitors of crystallisation" play any role in the prevention of kidney stones? A critique.
    Robertson WG.
    Urolithiasis; 2017 Feb; 45(1):43-56. PubMed ID: 27900407
    [Abstract] [Full Text] [Related]

  • 8. Calcium oxalate crystal growth in human urinary stones.
    Kim KM, Johnson FB.
    Scan Electron Microsc; 1981 Feb; (Pt 3):147-54. PubMed ID: 7330575
    [Abstract] [Full Text] [Related]

  • 9. Nucleation at surfaces: the importance of interfacial energy.
    Wu W, Gerard DE, Nancollas GH.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S355-8. PubMed ID: 10541263
    [Abstract] [Full Text] [Related]

  • 10. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M, Miyake O, Yoshimura K, Kakimoto KI, Takahara S, Okuyama A.
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [Abstract] [Full Text] [Related]

  • 11. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA, Hennequin C, Lacour B, Daudon M.
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [Abstract] [Full Text] [Related]

  • 12. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A, Isern B, Perelló J, Sanchis P, Grases F.
    Scand J Urol Nephrol; 2005 Sep; 39(3):194-9. PubMed ID: 16118089
    [Abstract] [Full Text] [Related]

  • 13. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
    Saw NK, Chow K, Rao PN, Kavanagh JP.
    J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
    [Abstract] [Full Text] [Related]

  • 14. Role of agglomeration in the early stages of papillar stone formation.
    Söhnel O, Grases F, Garcia-Ferragut L.
    Scanning Microsc; 1994 Jun; 8(3):513-21; discussion 521-2. PubMed ID: 7747153
    [Abstract] [Full Text] [Related]

  • 15. [Effects of diuretic therapy on spontaneous expulsion of urinary calculi, urinary pH, and crystalluria in lithiasic patients].
    Kaid-Omar Z, Belouatek A, Driouch A, Taleb-Bendiab H, Lacour B, Addou A, Daudon M.
    Prog Urol; 2001 Jun; 11(3):450-7. PubMed ID: 11512457
    [Abstract] [Full Text] [Related]

  • 16. Inhibitors of stone formation.
    Worcester EM.
    Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
    [Abstract] [Full Text] [Related]

  • 17. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F, Khan SR.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [Abstract] [Full Text] [Related]

  • 18. The mechanism of formation of renal stone crystals.
    Nancollas GH.
    Proc Eur Dial Transplant Assoc; 1983 Nov; 20():386-97. PubMed ID: 6361752
    [Abstract] [Full Text] [Related]

  • 19. [Molecular mechanism of renal stone formation].
    Hamamoto S, Taguchi K, Fujii Y.
    Clin Calcium; 2011 Oct; 21(10):1481-7. PubMed ID: 21960233
    [Abstract] [Full Text] [Related]

  • 20. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA, Asplin JR.
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.